Related Experiment Video
Updated: Jul 26, 2025
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
microRNA-based predictor for diagnosis of frontotemporal dementia
Iddo Magen1,2, Nancy-Sarah Yacovzada1,2, Jason D Warren3
1Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Aims:
This study aimed to explore the non-linear relationships between cell-free microRNAs (miRNAs) and their contribution to prediction of Frontotemporal dementia (FTD), an early onset dementia that is clinically heterogeneous, and too often suffers from delayed diagnosis.
Methods:
We initially studied a training cohort of 219 subjects (135 FTD and 84 non-neurodegenerative controls) and then validated the results in a cohort of 74 subjects (33 FTD and 41 controls).
Results:
On the basis of cell-free plasma miRNA profiling by next generation sequencing and machine learning approaches, we develop a non-linear prediction model that accurately distinguishes FTD from non-neurodegenerative controls in ~90% of cases.
Conclusions:
The fascinating potential of diagnostic miRNA biomarkers might enable early-stage detection and a cost-effective screening approach for clinical trials that can facilitate drug development.
Insights
This study developed a non-linear prediction model using cell-free microRNAs (miRNAs) to accurately detect Frontotemporal dementia (FTD) in ~90% of cases, aiding early diagnosis.
Area of Science:
- Biomarkers
- Neuroscience
- Genomics
Background:
- Frontotemporal dementia (FTD) is an early-onset neurodegenerative disease.
- FTD is clinically heterogeneous, often leading to delayed diagnosis.
- Accurate diagnostic tools for FTD are urgently needed.
Purpose of the Study:
- To explore non-linear relationships between cell-free microRNAs (miRNAs) and Frontotemporal dementia (FTD).
- To develop a predictive model for early FTD detection using cell-free miRNAs.
- To assess the potential of miRNAs as diagnostic biomarkers for FTD.
Main Methods:
- Utilized next-generation sequencing for cell-free plasma miRNA profiling.
- Employed machine learning approaches to develop a non-linear prediction model.
- Validated the model on independent training (219 subjects) and validation (74 subjects) cohorts.
Main Results:
- Developed a non-linear prediction model distinguishing FTD from controls with ~90% accuracy.
- Identified specific cell-free miRNA profiles associated with FTD.
- Demonstrated the potential of miRNA profiling in FTD diagnosis.
Conclusions:
- Cell-free miRNAs show promise as accurate biomarkers for Frontotemporal dementia (FTD).
- The developed non-linear model facilitates early-stage FTD detection.
- miRNA biomarkers could enable cost-effective screening and accelerate drug development for FTD.
